Czechia· CZ-0027881
GARDASIL
A humaner papillomvirus (typen 6, 11, 16, 18) product containing human papillomavirus type 6 l1 protein + human papillomavirus type 11 l1 protein + human papillomavirus type 16 l1 protein + human papillomavirus type 18 l1 protein, registered in Czechia by Merck Sharp & Dohme B.V., Haarlem. The same ATC class is registered in 8 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Humaner papillomvirus (typen 6, 11, 16, 18) is registered in 8 of 19 countries.
Countries holding a registration under ATC J07BM01 (humaner papillomvirus (typen 6, 11, 16, 18)), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Humaner papillomvirus (typen 6, 11, 16, 18) · ATC J07BM01
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN + HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN + HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN + HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
- Manufacturer
- Merck Sharp & Dohme B.V., Haarlem
- Country
- Czechia (CZ)
- ATC code
- J07BM01
- ATC class
- Humaner Papillomvirus (Typen 6, 11, 16, 18)
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Humaner papillomvirus (typen 6, 11, 16, 18) in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db98ee7c-2668-4efc-a7cf-a0a3da9960c3 GET /v1/drugs/db98ee7c-2668-4efc-a7cf-a0a3da9960c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SUS ISP",
"source": "sukl",
"strength": null,
"pack_size": "10X0,5ML",
"substance": "HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN + HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN + HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN + HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN",
"cz_kod_sukl": "0027881",
"product_type": "IM/BT",
"substance_codes": "17651,17652,17653,17654",
"registration_state": "R",
"registration_number": "EU/1/06/357/004"
}See everything about humaner papillomvirus (typen 6, 11, 16, 18).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.